Piramal Pharma Ltd Board to Meet April 28 for Consideration of FY and Q Results
Piramal Pharma Ltd announced that its Board of Directors will convene a meeting on Tuesday, April 28, 2026. The meeting is scheduled to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year that concluded on March 31, 2026.The company also provided an update regarding the trading window for its securities. The window, which had previously closed on Wednesday, April 1, 2026, will remain closed until Thursday, April 30, 2026, encompassing both days.PPLPHARMA Stock Price Movement
Shares of Piramal Pharma Limited are edging higher to ₹148.4 as of 2:25 PM today, gaining 0.61% in live trading. The...